UniProt ID | NR2C2_HUMAN | |
---|---|---|
UniProt AC | P49116 | |
Protein Name | Nuclear receptor subfamily 2 group C member 2 | |
Gene Name | NR2C2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 596 | |
Subcellular Localization | Nucleus . | |
Protein Description | Orphan nuclear receptor that can act as a repressor or activator of transcription. An important repressor of nuclear receptor signaling pathways such as retinoic acid receptor, retinoid X, vitamin D3 receptor, thyroid hormone receptor and estrogen receptor pathways. May regulate gene expression during the late phase of spermatogenesis. Together with NR2C1, forms the core of the DRED (direct repeat erythroid-definitive) complex that represses embryonic and fetal globin transcription including that of GATA1. Binds to hormone response elements (HREs) consisting of two 5'-AGGTCA-3' half site direct repeat consensus sequences. Plays a fundamental role in early embryonic development and embryonic stem cells. Required for normal spermatogenesis and cerebellum development. Appears to be important for neurodevelopmentally regulated behavior (By similarity). Activates transcriptional activity of LHCG. Antagonist of PPARA-mediated transactivation.. | |
Protein Sequence | MTSPSPRIQIISTDSAVASPQRIQIVTDQQTGQKIQIVTAVDASGSPKQQFILTSPDGAGTGKVILASPETSSAKQLIFTTSDNLVPGRIQIVTDSASVERLLGKTDVQRPQVVEYCVVCGDKASGRHYGAVSCEGCKGFFKRSVRKNLTYSCRSNQDCIINKHHRNRCQFCRLKKCLEMGMKMESVQSERKPFDVQREKPSNCAASTEKIYIRKDLRSPLIATPTFVADKDGARQTGLLDPGMLVNIQQPLIREDGTVLLATDSKAETSQGALGTLANVVTSLANLSESLNNGDTSEIQPEDQSASEITRAFDTLAKALNTTDSSSSPSLADGIDTSGGGSIHVISRDQSTPIIEVEGPLLSDTHVTFKLTMPSPMPEYLNVHYICESASRLLFLSMHWARSIPAFQALGQDCNTSLVRACWNELFTLGLAQCAQVMSLSTILAAIVNHLQNSIQEDKLSGDRIKQVMEHIWKLQEFCNSMAKLDIDGYEYAYLKAIVLFSPDHPGLTSTSQIEKFQEKAQMELQDYVQKTYSEDTYRLARILVRLPALRLMSSNITEELFFTGLIGNVSIDSIIPYILKMETAEYNGQITGASL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MTSPSPRIQ ------CCCCCCCEE | 49.71 | 20860994 | |
5 | Phosphorylation | ---MTSPSPRIQIIS ---CCCCCCCEEEEE | 26.95 | 17081983 | |
12 | Phosphorylation | SPRIQIISTDSAVAS CCCEEEEECCCCCCC | 27.99 | 23927012 | |
13 | Phosphorylation | PRIQIISTDSAVASP CCEEEEECCCCCCCC | 24.46 | 23927012 | |
13 (in isoform 2) | Phosphorylation | - | 24.46 | 24719451 | |
15 (in isoform 2) | Phosphorylation | - | 25.40 | 27251275 | |
15 | Phosphorylation | IQIISTDSAVASPQR EEEEECCCCCCCCCE | 25.40 | 23927012 | |
19 (in isoform 2) | Phosphorylation | - | 18.24 | 28985074 | |
19 | Phosphorylation | STDSAVASPQRIQIV ECCCCCCCCCEEEEE | 18.24 | 29255136 | |
27 | Phosphorylation | PQRIQIVTDQQTGQK CCEEEEEECCCCCCE | 29.71 | 20068231 | |
37 (in isoform 2) | Phosphorylation | - | 3.19 | 25627689 | |
38 (in isoform 2) | Phosphorylation | - | 1.29 | 25627689 | |
39 | Phosphorylation | GQKIQIVTAVDASGS CCEEEEEEEEECCCC | 23.69 | 28464451 | |
44 | Phosphorylation | IVTAVDASGSPKQQF EEEEEECCCCCCEEE | 35.03 | 30266825 | |
46 | Phosphorylation | TAVDASGSPKQQFIL EEEECCCCCCEEEEE | 26.82 | 29255136 | |
54 | Phosphorylation | PKQQFILTSPDGAGT CCEEEEEECCCCCCC | 33.14 | 30266825 | |
55 | Phosphorylation | KQQFILTSPDGAGTG CEEEEEECCCCCCCC | 19.97 | 30266825 | |
61 | Phosphorylation | TSPDGAGTGKVILAS ECCCCCCCCEEEEEC | 33.04 | 29255136 | |
63 | Ubiquitination | PDGAGTGKVILASPE CCCCCCCEEEEECCC | 26.41 | - | |
65 (in isoform 2) | Phosphorylation | - | 2.79 | 24719451 | |
68 | Phosphorylation | TGKVILASPETSSAK CCEEEEECCCCCCCC | 21.59 | 30266825 | |
71 | Phosphorylation | VILASPETSSAKQLI EEEECCCCCCCCEEE | 31.22 | 30266825 | |
72 | O-linked_Glycosylation | ILASPETSSAKQLIF EEECCCCCCCCEEEE | 27.00 | 31492838 | |
72 | Phosphorylation | ILASPETSSAKQLIF EEECCCCCCCCEEEE | 27.00 | 30266825 | |
73 | Phosphorylation | LASPETSSAKQLIFT EECCCCCCCCEEEEE | 47.08 | 30266825 | |
73 (in isoform 2) | Phosphorylation | - | 47.08 | 27251275 | |
82 (in isoform 2) | Ubiquitination | - | 22.80 | - | |
87 (in isoform 2) | Phosphorylation | - | 29.52 | 24719451 | |
94 | Phosphorylation | PGRIQIVTDSASVER CCCEEEEECCHHHHH | 26.35 | 30266825 | |
96 | Phosphorylation | RIQIVTDSASVERLL CEEEEECCHHHHHHH | 17.05 | 30266825 | |
98 | Phosphorylation | QIVTDSASVERLLGK EEEECCHHHHHHHCC | 28.59 | 30266825 | |
115 (in isoform 2) | Phosphorylation | - | 34.07 | 24719451 | |
116 | Phosphorylation | QRPQVVEYCVVCGDK CCCEEEEEEEEECCC | 4.48 | - | |
117 (in isoform 2) | Phosphorylation | - | 0.87 | 27251275 | |
189 | Phosphorylation | MKMESVQSERKPFDV CCHHHHHCCCCCCCC | 36.89 | 28555341 | |
192 | Ubiquitination | ESVQSERKPFDVQRE HHHHCCCCCCCCCCC | 46.08 | - | |
192 | Sumoylation | ESVQSERKPFDVQRE HHHHCCCCCCCCCCC | 46.08 | 28112733 | |
200 | Acetylation | PFDVQREKPSNCAAS CCCCCCCCCCCCCCC | 56.80 | 25953088 | |
207 | Phosphorylation | KPSNCAASTEKIYIR CCCCCCCCCCEEEEE | 20.69 | 28348404 | |
208 | Phosphorylation | PSNCAASTEKIYIRK CCCCCCCCCEEEEEC | 36.25 | 28985074 | |
219 | Phosphorylation | YIRKDLRSPLIATPT EEECCCCCCCEECCC | 31.21 | 29255136 | |
224 | Phosphorylation | LRSPLIATPTFVADK CCCCCEECCCEEECC | 18.83 | 25159151 | |
226 | Phosphorylation | SPLIATPTFVADKDG CCCEECCCEEECCCC | 26.79 | 21712546 | |
231 | Ubiquitination | TPTFVADKDGARQTG CCCEEECCCCCCCCC | 48.61 | - | |
231 | Acetylation | TPTFVADKDGARQTG CCCEEECCCCCCCCC | 48.61 | 23954790 | |
238 (in isoform 2) | Phosphorylation | - | 18.86 | 24719451 | |
243 (in isoform 2) | Phosphorylation | - | 23.02 | 24719451 | |
322 | Phosphorylation | TLAKALNTTDSSSSP HHHHHHCCCCCCCCC | 32.60 | 29978859 | |
323 | Phosphorylation | LAKALNTTDSSSSPS HHHHHCCCCCCCCCC | 32.58 | 29978859 | |
325 | Phosphorylation | KALNTTDSSSSPSLA HHHCCCCCCCCCCCC | 29.99 | 29978859 | |
326 | Phosphorylation | ALNTTDSSSSPSLAD HHCCCCCCCCCCCCC | 37.33 | 29978859 | |
327 | Phosphorylation | LNTTDSSSSPSLADG HCCCCCCCCCCCCCC | 50.66 | 25850435 | |
328 | Phosphorylation | NTTDSSSSPSLADGI CCCCCCCCCCCCCCE | 22.06 | 23401153 | |
330 | Phosphorylation | TDSSSSPSLADGIDT CCCCCCCCCCCCEEC | 37.83 | 28464451 | |
337 | Phosphorylation | SLADGIDTSGGGSIH CCCCCEECCCCCEEE | 27.61 | 29978859 | |
338 | Phosphorylation | LADGIDTSGGGSIHV CCCCEECCCCCEEEE | 31.52 | 29978859 | |
342 | Phosphorylation | IDTSGGGSIHVISRD EECCCCCEEEEEECC | 16.88 | 29978859 | |
346 (in isoform 2) | Phosphorylation | - | 1.40 | 24719451 | |
347 (in isoform 2) | Phosphorylation | - | 28.81 | 27251275 | |
347 | Phosphorylation | GGSIHVISRDQSTPI CCEEEEEECCCCCCE | 28.81 | 29978859 | |
351 | Phosphorylation | HVISRDQSTPIIEVE EEEECCCCCCEEEEE | 40.20 | 29255136 | |
352 | Phosphorylation | VISRDQSTPIIEVEG EEECCCCCCEEEEEC | 16.93 | 29255136 | |
363 | Phosphorylation | EVEGPLLSDTHVTFK EEECCCCCCCEEEEE | 48.42 | 23403867 | |
365 | Phosphorylation | EGPLLSDTHVTFKLT ECCCCCCCEEEEEEE | 18.18 | 23403867 | |
368 | Phosphorylation | LLSDTHVTFKLTMPS CCCCCEEEEEEECCC | 13.88 | 23403867 | |
370 (in isoform 2) | Phosphorylation | - | 33.41 | 27251275 | |
371 (in isoform 2) | Phosphorylation | - | 4.30 | 24719451 | |
516 | Ubiquitination | TSTSQIEKFQEKAQM CCHHHHHHHHHHHHH | 54.71 | - | |
531 | Ubiquitination | ELQDYVQKTYSEDTY HHHHHHHHHCCHHHH | 39.11 | - | |
550 (in isoform 2) | Ubiquitination | - | 4.00 | - | |
571 | Phosphorylation | TGLIGNVSIDSIIPY CCCCCCEEHHHHHHH | 25.36 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
19 | S | Phosphorylation | Kinase | MAPK-FAMILY | - | GPS |
19 | S | Phosphorylation | Kinase | MAPK | - | Uniprot |
55 | S | Phosphorylation | Kinase | MAPK | - | Uniprot |
68 | S | Phosphorylation | Kinase | MAPK-FAMILY | - | GPS |
68 | S | Phosphorylation | Kinase | MAPK | - | Uniprot |
- | K | Ubiquitination | E3 ubiquitin ligase | TRAF6 | Q9Y4K3 | PMID:15492226 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NR2C2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
HDAC3_HUMAN | HDAC3 | physical | 12943985 | |
HDAC4_HUMAN | HDAC4 | physical | 12943985 | |
ESR1_HUMAN | ESR1 | physical | 11844790 | |
ANDR_HUMAN | AR | physical | 10611280 | |
HNF4A_HUMAN | HNF4A | physical | 12522137 | |
RXRB_HUMAN | RXRB | physical | 15604093 | |
TAB1_HUMAN | TAB1 | physical | 22158122 | |
PDLI7_HUMAN | PDLIM7 | physical | 16446357 | |
TAB2_HUMAN | TAB2 | physical | 20064081 | |
TRAF6_HUMAN | TRAF6 | physical | 20064081 | |
JAZF1_HUMAN | JAZF1 | physical | 15302918 | |
NR2C2_HUMAN | NR2C2 | physical | 15302918 | |
KDM1A_HUMAN | KDM1A | physical | 23455924 | |
DDB1_HUMAN | DDB1 | physical | 24703702 | |
DCAF1_HUMAN | VPRBP | physical | 24703702 | |
CUL4B_HUMAN | CUL4B | physical | 24703702 | |
S10A4_HUMAN | S100A4 | physical | 26496610 | |
SMRC1_HUMAN | SMARCC1 | physical | 26496610 | |
EED_HUMAN | EED | physical | 26496610 | |
RPP38_HUMAN | RPP38 | physical | 26496610 | |
PATZ1_HUMAN | PATZ1 | physical | 26496610 | |
TANC2_HUMAN | TANC2 | physical | 26496610 | |
RBMX2_HUMAN | RBMX2 | physical | 26496610 | |
PR40A_HUMAN | PRPF40A | physical | 26496610 | |
KLHL7_HUMAN | KLHL7 | physical | 26496610 | |
UBB_HUMAN | UBB | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19 AND SER-46, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-219 AND THR-224, ANDMASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-68, AND MASSSPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-68, AND MASSSPECTROMETRY. |